scispace - formally typeset
W

Wolf H. Fridman

Researcher at University of Paris

Publications -  551
Citations -  60835

Wolf H. Fridman is an academic researcher from University of Paris. The author has contributed to research in topics: Immune system & Receptor. The author has an hindex of 97, co-authored 525 publications receiving 48713 citations. Previous affiliations of Wolf H. Fridman include Queen Elizabeth Hospital Birmingham & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura

TL;DR: The infusion of Fcγ fragments is an efficient treatment of acute ITP in children and strengthens the hypothesis that F cγR blockade is the main mechanism of action of IVIG in ITP, although other immunoregulatory mechanisms triggered by the presence of increased sCD16 concentrations in serum could be involved in the clinical benefit observed.
Journal Article

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

TL;DR: It was shown that in vitro, IL-17 increases IL-6 and IL-8 secretion by cervical carcinoma cell lines at both protein and mRNA levels, and behaves like a T-cell-specific cytokine with paradoxical tumor-promoting activity.
Journal ArticleDOI

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

TL;DR: In preclinical models, antiangiogenic molecules promoted intratumor trafficking of effector cells, enhance endogenous anti-tumor response, and synergyzed with immunotherapy protocols to cure established murine tumors warrant the development of clinical trials combining antiangIogenic drugs and immunotherapy.